Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1253/circj.CJ-66-0233 | DOI Listing |
J Thorac Dis
December 2024
Department of Cardiothoracic Surgery, Instituto Nacional de Cardiologia Ignacio Chávez, Mexico City, Mexico.
Background: Takayasu arteritis (TA) affects medium and large caliber arteries causing stenosis, occlusion, or aneurysms. It has great predilection for the aortic arch, subclavian and extracranial arteries. The global prevalence is of 1% to 2% per million inhabitants, which varies by geographical region.
View Article and Find Full Text PDFJ Intensive Care Med
January 2025
Elmhurst Hospital, New York City Health & Hospitals Corporation, Queens, NY, USA.
Cardiovascular disease (CVD) is the leading cause of pregnancy-related mortality in the United States, with an incidence that has increased from 7.2 to 32.9 fatalities per 100,000 live births in the last 3 decades.
View Article and Find Full Text PDFNutrients
January 2025
Department of Clinical Nutrition and Dietetics, College of Health Sciences, University of Sharjah, Sharjah P.O. Box 27272, United Arab Emirates.
Background: Artificial Intelligence (AI) technologies are now essential as the agenda of nutrition research expands its scope to look at the intricate connection between food and health in both an individual and a community context. AI also helps in tracing and offering solutions in dietary assessment, personalized and clinical nutrition, as well as disease prediction and management, such as cardiovascular diseases, diabetes, cancer, and obesity. This review aims to investigate and assess the different applications and roles of AI in nutrition and research and understand its potential future impact.
View Article and Find Full Text PDFFront Oncol
December 2024
Clinical Medical College, Yangzhou University, Yangzhou, Jiangsu, China.
Curr Protein Pept Sci
December 2024
Department of Pharmacy, Galgotias University, Greater Noida, Uttar Pradesh 201310, India.
TLR4 stands at the forefront of innate immune responses, recognizing various pathogen- associated molecular patterns and endogenous ligands, thus serving as a pivotal mediator in the immune system's defense against infections and tissue damage. Beyond its canonical role in infection, emerging evidence highlights TLR4's involvement in numerous non-infectious human diseases, ranging from metabolic disorders to neurodegenerative conditions and cancer. Targeting TLR4 signaling pathways presents a promising therapeutic approach with broad applicability across these diverse pathological states.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!